In Teva Branded Pharm. Prods. R&D v. Amneal Pharms. of N.Y., LLC, the US District Court for the District of New Jersey ordered Teva to delist ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

Delivery of asthma medication with pressurized metered-dose inhalers is economical, effective, and convenient. This method of delivery is a critical part of the medical management program for most ...

Pressurised metered dose inhalers (pMDI) delivering drugs for asthma, chronic obstructive pulmonary disease and other respiratory diseases currently use hydrofluorocarbon (HFC) propellants that ...

The global metered dose inhalers (MDI) market is poised for significant growth, with an estimated market size of USD 26,322.9 million in 2023, up from USD 25,208.9 million in 2022. According to a ...

Our Nursing in Practice quick quizzes aim to test your knowledge through a series of illustrative cases and scenarios. Work ...

In conclusion, the Easyhaler ® more closely demonstrates the characteristics of an ‘ideal inhaler' than its competitors ... price comparable to that of an MDI. Consistency in the fine particle ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

The propellants used in metered-dose inhalers (MDIs) have always contributed significantly to greenhouse gas emissions. Although the 1990s saw a switch from MDIs using ozone-depleting ...

Pharmaceutical companies are looking to change that with lower-emitting inhalers that they plan to roll out by the end of the decade. Metered-dose inhalers – pressurized devices that release a ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...